Saturday 17 October 2026 Export RIGL’s income statement to Excel — free account

Rigel Pharmaceuticals, Inc.

Rigel Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $294.3 million, up 64.1% from fiscal 2024. In the quarter to June 2026, revenue fell 22.6%, EPS fell 72.1%, free cash flow fell 230.0% and total debt fell 66.6%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

45.97 1.28 −2.71%

Follow RIGL

Alert me

Market cap: $882.6M
P/E: 2.6×
Fwd P/E: 7.9×
Dividend yield: —
F-score: 6/9
Altman Z: 2.70
Beneish M: 0.78
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	4	6	6	7	+8 more TTM periods Free account
ROE Full definition →	126.90%	174.08%	185.94%	220.06%
ROA Full definition →	88.46%	107.04%	108.34%	59.33%
ROIC Full definition →	16.48%	29.03%	30.28%	712.45%
Return on Tangible Assets Full definition →	357.90%	252.00%	260.43%	93.96%
Average Days of Receivables Full definition →	73.90	60.81	64.20	59.43
Free Cash Flow per Share Full definition →	0.48	4.31	4.21	3.79
Free Cash Flow Full definition →	8.82	79.27	75.66	68.34
Capital Expenditures Full definition →	(70.57)	—	—	0.16
Other line items
Cash ROIC Full definition →	1.69%	14.12%	13.30%	24.00%
Accounts Receivable Turnover Full definition →	5.77	6.55	6.30	7.37
Accounts Payable Turnover Full definition →	4.22	4.70	3.73	5.08
Inventory Turnover Full definition →	1.92	2.43	2.24	2.15
Average Days of Payables Full definition →	61.41	82.62	133.77	72.16
Days of Inventory on Hand Full definition →	219.97	214.60	214.04	249.58
Tax Rate Full definition →	2.76	1.99	2.01	0.00
Research and Development Expense of Revenue Full definition →	15.78%	12.19%	11.31%	10.01%
Selling, General and Administrative Expense of Revenue Full definition →	44.16%	39.64%	39.38%	40.92%
Share Based Compensation of Revenue Full definition →	5.93%	4.28%	4.32%	4.27%
Interest Coverage Full definition →	15.00	18.05	17.14	15.70
Operating CF/Net income Full definition →	0.25	0.22	0.21	0.60
Depreciation/Fixed assets Full definition →	0.00	0.00	0.00	22.87
Capex/Depreciation Full definition →	(40.70)	0.00	0.00	0.13
Revenue per Share Full definition →	14.93	16.28	16.36	15.64
Operating CF per Share Full definition →	4.28	4.31	4.21	3.78
Capex per Share Full definition →	(3.81)	0.00	0.00	0.01
Capex to Sales Full definition →	0.26	0.00	0.00	0.00

Fold the line items

Columns are period end dates

Stockrow Weekly